What Are Pharma Cold Chain Standards in 2025?
In 2025 the pharmaceutical cold chain has become a critical pillar of global health. Pharma cold chain standards ensure that temperature sensitive medicines – from routine vaccines to gene therapies – are stored, transported and handled within precise temperature ranges to preserve their efficacy. Meeting these standards not only protects patients but also reduces waste and legal risk. The booming market for biologics and cell therapies (forecast to top US $65 billion by 2025) and the looming DSCSA deadlines for digital traceability underscore why every stakeholder must understand and implement robust cold chain practices.
What are the key elements of pharmaceutical cold chain standards? – including temperature ranges, equipment requirements and regulatory frameworks.
How do packaging and shipping standards protect medicines? – covering insulated containers, phase change materials and international shipping rules.
What new regulations and compliance obligations take effect in 2025? – detailing DSCSA deadlines, GDP guidelines and URAC 5.0 requirements.
Which technologies and trends are shaping the cold chain? – such as IoT sensors, AI analytics, blockchain and sustainable packaging.
How can healthcare providers store and handle vaccines safely? – practical tips based on CDC and AAAHC guidance.
What are the 2025 market trends and future directions? – including automation, sustainability and industry consolidation.
What Are Pharma Cold Chain Standards and Why Do They Matter?
Pharmaceutical cold chain standards refer to the codified requirements that ensure temperature sensitive products maintain their quality and safety from manufacturer to patient. Good Distribution Practice (GDP) guidelines state that medicines must be stored and transported within approved temperature ranges, typically 2 °C to 8 °C for refrigerated products, with validated equipment, continuous monitoring and comprehensive documentation. These standards minimise risk of degradation and protect public health; failure can lead to wasted products, regulatory penalties and reputational damage.
Regulators around the world enforce these requirements. The European Medicines Agency (EMA) notes that GDP ensures authorised medicines are handled in suitable conditions, contamination is avoided and a system for tracing and recall is in place. In the United States, the Drug Supply Chain Security Act (DSCSA) mandates package level tracking and electronic data exchange by August 27 2025 for wholesalers and November 27 2025 for large dispensers. The act’s deadlines have already been extended to address data accuracy challenges. Meanwhile, URAC’s accreditation standards require specialty pharmacies to validate their storage and delivery programs through continuous monitoring.
Temperature Ranges for Different Pharmaceuticals
Proper temperature control is the foundation of any cold chain. Standard vaccines like influenza or tetanus require refrigeration between 2 °C and 8 °C; freezing can cause irreversible reactions while overheating reduces potency. HPV vaccines must also stay within 2 °C to 8 °C, where freezing results in permanent potency loss. COVID 19 vaccines vary: Pfizer BioNTech’s formulation needs ultra cold storage (–80 °C to –60 °C) and Moderna’s vaccine requires –25 °C to –15 °C but may be refrigerated for up to 30 days. Gene and cell therapies often demand temperatures below –70 °C.
The U.S. Pharmacopeia Chapter <1079> adds further granularity: room temperature pharmaceuticals are stored at 20 °C–25 °C with allowable excursions between 15 °C and 30 °C; cool storage is 8 °C–15 °C; refrigerators must hold 2 °C–8 °C; and freezers maintain –25 °C to –10 °C. Using medical grade equipment with microprocessor based control and fan forced air distribution helps achieve these ranges.
Table 1 – Typical Storage Temperatures and Implications
| Product type | Recommended storage range | Consequence of deviation | Practical implications |
| Standard vaccines (e.g., influenza, tetanus) | 2 °C–8 °C | Freezing can cause irreversible reactions; overheating lowers potency | Use dedicated vaccine refrigerators and avoid placing vials near walls or doors |
| HPV vaccines | 2 °C–8 °C | Permanent loss of potency if frozen | Monitor continuously with calibrated thermometers and alarms |
| COVID 19 mRNA vaccines (Pfizer) | –80 °C to –60 °C | Loss of efficacy if temperature rises | Invest in portable cryogenic freezers and validate shipping solutions |
| COVID 19 vaccines (Moderna) | –25 °C to –15 °C (refrigeration possible 2 °C–8 °C for up to 30 days) | Extended room temperature exposure shortens shelf life | Plan shipping times carefully and coordinate with receiving sites to minimize delays |
| Gene and cell therapies | –70 °C or lower | Degradation leads to loss of therapeutic value | Use specialized ultra cold freezers and real time monitoring |
| Frozen biologics and live vaccines | –15 °C to –50 °C | Structural damage and reduced efficacy | Employ pharmaceutical grade freezers; avoid frost build up and defrost per SOP |
| Room temperature medications | 20 °C–25 °C with short term excursions 15 °C–30 °C | Potency loss and patient harm | Even “room temperature” drugs require climate controlled storage and monitoring |
Practical Tips and Recommendations
Select appropriate storage equipment: Use pharmaceutical grade refrigerators and freezers with electronic thermostats, alarms and interior fans. Household units or dormitory style refrigerators are not acceptable because they risk freezing vaccines.
Monitor continuously: Place calibrated digital data loggers with buffered probes in every storage unit. Check and record temperatures twice daily, ideally at the beginning and end of the workday. Choose monitoring systems that issue alerts during temperature excursions.
Train staff and maintain documentation: Staff must document readings, maintenance schedules and deviations. Training should cover recognition of compromised products and emergency protocols.
Plan for contingencies: Keep backup power supplies, spare monitoring devices and alternative storage locations on hand. Develop step by step procedures for handling temperature instability and place them near each unit.
Case example: A community pharmacy replaced a household refrigerator with a pharmaceutical grade unit after repeated excursions. By using digital data loggers and clear temperature labels, it reduced product waste by 20 % and improved inspection compliance.
How Do Packaging and Shipping Standards Protect Medicines?
Packaging and shipping standards safeguard pharmaceutical products against environmental stress during transit. International bodies like the World Health Organization (WHO) and the International Air Transport Association (IATA) prescribe criteria for insulated containers, coolants and handling procedures. WHO’s guidelines for international shipment of vaccines require shipping containers to be durable, protect against mechanical handling and environmental conditions and undergo qualification testing under ASTM/ISTA protocols. They recommend water based coolant packs or phase change materials for most shipments and advise phasing out dry ice except for ultra low temperature transport; when dry ice is used, packages must be vented and labelled appropriately.
The IATA Temperature Control Regulations (TCR) set specific packaging, documentation and handling requirements for air transport. The 14th edition, effective 2026, introduces new training recommendations and revises acceptance and storage procedures, including removal of imperial units in favour of the metric system and updated packaging and labelling instructions. These changes emphasise global harmonisation and accuracy.
Packaging materials play an equally important role. Vacuum insulation panels (VIPs) and phase change materials (PCMs) offer superior insulation and thermal stability. The 2025 monitoring guide notes that VIPs and PCMs can be custom shaped and provide longer hold times for 2–8 °C shipments. Gel packs and reusable pallet shippers with built in IoT sensors maintain temperature for 96 hours and issue alerts during excursions. For ultra cold shipments, portable cryogenic shippers maintain –80 °C to –150 °C and reduce reliance on dry ice.
Table 2 – Packaging and Coolant Options
| Packaging solution | Description | Practical benefit |
| Insulated containers with gel packs | Foam or plastic boxes lined with insulation and reusable gel packs for 2–8 °C products | Cost effective and easy to prepare; suitable for short haul shipments and vaccines |
| Phase change materials (PCMs) | Materials that change phase at predetermined temperatures (e.g., +4 °C). Provide stable thermal environment | Extend hold time and minimize excursions; ideal for long haul or extreme weather |
| Vacuum insulation panels (VIPs) | Thin panels with near vacuum cores offering high thermal resistance | Allow lighter and more compact packaging with long hold times; reduce refrigerant volume |
| Portable cryogenic shippers | Reusable freezers that maintain –80 °C to –150 °C | Support transport of gene and cell therapies; reduce dry ice usage and provide real time monitoring |
| Recycled and biodegradable materials | Sustainable packaging made from recycled plastics, plant based fibres and biodegradable wraps | Reduce waste and appeal to environmentally conscious customers; can be reused multiple times |
Practical Packaging Advice
Validate packaging to recognized standards: Choose solutions tested under ISTA 7D or GDP standards and request validation reports from providers.
Match coolant and duration: Ensure the combination of container and refrigerant maintains the required temperature range for the entire shipping duration (e.g., 2–8 °C for 96 hours).
Consider reusable versus single use: Evaluate costs and environmental impact. Reusable systems often provide better return on investment and support sustainability goals.
Integrate digital monitoring: Use packaging that integrates sensors and geofencing to provide real time temperature and location data.
Practical scenario: A vaccine distributor shipping from California to rural Alaska used IoT equipped insulated pallet shippers. When a refrigeration unit failed mid route, sensors detected a temperature spike and triggered a route change to a nearby warehouse, preventing spoilage.
What New Regulations and Compliance Obligations Take Effect in 2025?
DSCSA and Global Traceability
The Drug Supply Chain Security Act (DSCSA) imposes strict electronic traceability requirements for prescription drugs in the U.S. Starting May 27 2025, manufacturers and repackagers must exchange transaction information electronically; wholesale distributors must comply by August 27 2025, and dispensers with more than 26 employees by November 27 2025. The DSCSA replaces paper based transaction histories with serialized data exchange and requires stakeholders to verify product identifiers at the package level. Failing to comply can result in fines up to US $500 000 and license revocation. A stabilization period in 2023 allowed more time for stakeholders to upgrade systems.
The act aligns with global initiatives. The European Union’s GDP and GMP Annex 11 require validated electronic systems with audit trails and secure data handling. The EU Clinical Trials Regulation and various national guidelines (e.g., UK’s MHRA) emphasise calibration standards like NIST and UKAS. Worldwide, regulators adopt WHO vaccine storage guidelines and require digital monitoring for compliance.
URAC 5.0 and Specialty Pharmacy Accreditation
For specialty pharmacies, the updated URAC 5.0 standards introduce distribution management requirements. Pharmacies must define evidence based temperature ranges for each medication type (frozen, refrigerated and room temperature), determine appropriate packaging and shipping durations and perform qualification testing under all defined conditions. These standards give pharmacies flexibility to tailor their cold chain strategies while demonstrating compliance during audits. URAC also insists that organizations continuously monitor storage and delivery programs.
Temperature Mapping and Monitoring Requirements
The WHO’s Effective Vaccine Management (EVM) initiative requires temperature mapping of cold and freezer rooms at least every two years. Temperature mapping records the temperature within a three dimensional space because variations can reach 10 °C between different points in the same unit. WHO released an updated temperature mapping tool in June 2024 that includes built in user guidance. Organizations should also follow separate user guides for those with limited computer skills.
IATA and Regional Regulations
The IATA’s 14th edition Temperature Control Regulations (effective 2026) revises packaging, handling and training requirements for air transport, promoting adoption of the metric system and more detailed acceptance checks. Local authorities, such as the U.S. FDA and Canada’s Transport of Dangerous Goods regulations, also publish operator variations that carriers must follow. Adherence to these rules ensures safe and lawful shipping of pharmaceutical products.
Table 3 – Key Regulatory Frameworks and Requirements
| Regulation / standard | Key requirements | Deadlines or updates |
| DSCSA (U.S.) | Electronic transaction information and statements; package level serialization; verification of product identifiers | Manufacturers & repackagers: May 27 2025; wholesalers: Aug 27 2025; dispensers (>26 employees): Nov 27 2025 |
| EU GDP & GMP Annex 11 | Temperature control, traceability, risk management and validated electronic systems | Continuous; national authorities resumed on site inspections after pandemic flexibilities ended |
| WHO vaccine guidelines | Qualified shipping containers, durable coolants, temperature mapping every two years | Latest mapping tool released June 2024 |
| URAC 5.0 (specialty pharmacies) | Evidence based temperature ranges; packaging & shipping requirements; qualification testing | Standards implemented in 2024 for accreditation; compliance required for 2025 audits |
| IATA Temperature Control Regulations (14th edition) | Revised packaging and training guidelines; metric system adoption; operator variations | Effective 2026; companies should prepare now |
Compliance Tips
Digitize documentation: Centralize transaction data in secure cloud platforms to meet DSCSA requirements. Use Electronic Product Code Information Services (EPCIS) formats for interoperability.
Validate equipment and processes: Calibrate sensors and loggers to recognized standards (NIST or UKAS) and perform regular audits.
Implement continuous training: Train staff on regulatory updates, temperature mapping procedures and emergency response. Include scenario based drills as recommended by AAAHC’s Quality Roadmap.
Monitor operator variations: Airlines and ground handlers often publish operator specific requirements. Review and integrate them into your shipping SOPs.
Case example: A wholesaler preparing for DSCSA compliance upgraded its ERP system to support package level serialization and invested in EPCIS based interfaces. During pilot testing, mismatches between physical product and electronic data triggered quarantines, prompting process adjustments. Early implementation ensured the company met the August 2025 deadline and avoided penalties.
Which Technologies and Innovations Are Transforming the Cold Chain?
Technological advances are reshaping the cold chain, improving visibility, efficiency and sustainability. Here are the major innovations:
IoT Sensors and Real Time Monitoring
Internet of Things (IoT) devices collect temperature, humidity and location data continuously and transmit it to cloud platforms. Real time monitoring enables unbroken visibility across storage and transportation, helping companies meet compliance requirements. Hardware such as wireless sensors, RFID, GPS trackers and Bluetooth loggers is responsible for 76 % of the market share. Predictive analytics built on IoT data can reduce equipment downtime by up to 50 % and lower repair costs by 10–20 %.
Artificial Intelligence and Predictive Analytics
AI algorithms analyse historical and real time data to forecast equipment failures, predict demand and optimize logistics. AI driven route optimization uses traffic and weather data to reduce transit times and limit temperature excursions. Predictive maintenance prevents spoilage by triggering alerts before a refrigeration unit fails, as demonstrated in the Alaska shipping case.
Blockchain for End to End Traceability
Blockchain creates immutable records of each transaction and storage condition, ensuring data integrity and deterring counterfeits. When integrated with IoT sensors, blockchain provides tamper proof temperature, humidity and transit data. This transparency simplifies audits and improves trust among stakeholders.
Drone Deliveries and Remote Access
Drones enable contactless delivery to remote areas, reducing last mile transit times and supporting emergency medical campaigns. B Medical Systems and other innovators highlight that drones provide rapid, traceable deliveries of vaccines and biologics to hard to reach communities. Combined with solar powered cold storage units, drones expand access to essential medicines in regions with unreliable electricity.
Sustainable Refrigeration and Packaging
The cold chain is resource intensive; its infrastructure is responsible for approximately 2 % of global CO₂ emissions. Sustainable solutions include energy efficient refrigeration, renewable energy sources and eco friendly packaging. Solar powered cold storage reduces energy costs, particularly where commercial electricity rates exceed 13 cents per kWh. Recyclable insulation, biodegradable mailers and reusable pallet shippers lower environmental impact.
Robotics and Automation
Automation addresses labor shortages and increases efficiency in cold storage facilities. Automated storage and retrieval systems (AS/RS) and robotic handling reduce errors and maintain consistent temperature conditions. Only 20 % of warehouses were automated in 2025, indicating significant growth potential. Robotics also enable high density storage and integration with warehouse management systems.
Emerging Regional Innovations
Southeast Asia is a hub for cold chain innovation. Companies there are piloting blockchain based tracking systems, solar powered storage units and AI assisted route optimization. Portable cryogenic freezers support ultra cold transport in remote areas and reduce dependence on dry ice.
Table 4 – Emerging Technologies and Benefits
| Innovation | Description | Benefit to your operations |
| IoT & real time monitoring | Sensors collect continuous temperature, humidity and location data | Immediate alerts for temperature excursions; enables predictive maintenance and compliance |
| AI & predictive analytics | AI analyses data to optimize routes and forecast equipment failures | Reduces spoilage and maintenance costs; enhances demand forecasting |
| Blockchain traceability | Immutable ledger records every shipment and temperature reading | Ensures data integrity, prevents counterfeiting and simplifies audits |
| Drone delivery | Unmanned aerial vehicles transport medicines to remote locations | Shorter delivery times and improved access to rural or disaster affected areas |
| Solar powered cold storage | Refrigeration units powered by solar energy | Cuts energy costs and supports operations in off grid areas |
| Robotics & automation | Automated storage systems and robotic handlers | Reduces labor dependency, increases throughput and maintains consistent conditions |
| Portable cryogenic freezers | Compact units maintaining –80 °C to –150 °C | Supports ultra cold shipments without extensive infrastructure |
Implementation Tips
Start small with pilots: Implement IoT sensors and analytics on a single route or facility, then expand once benefits are proven.
Integrate systems: Ensure monitoring devices feed data into your existing enterprise resource planning (ERP) or warehouse management systems for consolidated visibility.
Evaluate partners carefully: Choose providers that offer validated technology, predictive analytics and global support.
Combine sustainability with innovation: Opt for energy efficient equipment and reusable packaging to reduce carbon footprint while improving performance.
Illustrative case: A cold chain operator introduced AI enabled route optimisation and blockchain based tracking in Southeast Asia. The combined system reduced delivery times by 25 %, slashed spoilage rates and provided tamper proof documentation, leading to faster regulatory approvals.
How to Store and Handle Temperature Sensitive Medicines in Practice
While regulations and technology provide a framework, daily practices ensure that medicines remain potent. The CDC’s Vaccine Storage and Handling Toolkit (updated March 2024) and AAAHC’s guidance emphasise the following:
Storage Best Practices
Use pharmaceutical grade equipment: Refrigerators designed for vaccines include electronic thermostats, audible alarms and fans to maintain uniform temperatures. Avoid dormitory style units.
Position vaccines correctly: Store vials in the middle of shelves, away from walls, doors and the floor to minimise temperature fluctuations. Do not place vaccines in vegetable bins or near household items.
Maintain inventory: Rotate stock based on expiration dates and record vaccine orders and inventory levels; remove expired doses promptly.
Monitor and document temperatures: Record readings at least twice daily and ensure calibration certificates are current.
Prepare for emergencies: Keep backup power sources, transport containers and emergency contact information readily available.
Transportation and Handling
Pre condition containers: Pre cool refrigerators and insulated boxes before loading medicines.
Avoid overcrowding: Leave space around packages to allow air circulation and prevent cold spots.
Label clearly: Mark packages with the required temperature range and “refrigerated” or “frozen” instructions.
Educate patients: Inform patients to refrigerate medications immediately upon receipt and provide home storage instructions.
Plan for last mile delivery: Use validated shippers that maintain temperature beyond transit time and consider requiring signatures to ensure proper handling.
Table 5 – Vaccine and Biologic Temperature Ranges
| Category | Temperature range | Key considerations |
| Refrigerated vaccines | 2 °C–8 °C | Store in dedicated refrigerators; keep away from walls and doors |
| Frozen biologics | –25 °C to –15 °C (–13 °F to 5 °F) | Use freezers designed for biologics; avoid frost build up and defrost per SOP |
| Ultra cold therapies | –90 °C to –60 °C | Invest in portable cryogenic units; verify temperature with specialized probes before dispensing |
| Room temperature drugs | 20 °C–25 °C (68 °F–77 °F) with short term excursions allowed | Use climate controlled storage; avoid extreme heat or cold in dispensing areas |
Real world example: During a summer heatwave a specialty pharmacy’s digital logger alerted staff when a refrigerator reached 9 °C. Staff responded within minutes, moved stock to a backup unit and avoided losing over US $50 000 worth of biologics.
2025 Market Trends and Future Directions
The pharmaceutical cold chain is expanding rapidly. Market analyses predict the pharmaceutical cold chain packaging market will reach US $27.7 billion in 2025 and exceed US $102 billion by 2034. Reusable packaging alone is expected to double from US $2.5 billion in 2024 to about US $5 billion by 2033. Here are the key trends shaping the next decade:
Automation and Robotics
Automated storage and retrieval systems, robotic handlers and conveyor systems are addressing labour shortages and improving efficiency. Only 20 % of warehouses were automated in 2025, indicating huge growth potential.
Sustainability as a Core Value
Seventy seven percent of supply chain leaders consider sustainability a priority. Reusable and recyclable packaging, biodegradable mailers and plant based insulation reduce waste and appeal to eco conscious consumers. Companies like Cold Chain Technologies have demonstrated that sustainable packaging can reduce excess packaging while maintaining performance.
End to End Visibility and AI
Real time tracking and AI driven analytics provide end to end visibility and predictive capabilities. Software adoption is expected to grow at a 23.72 % CAGR between 2025 and 2034. This growth is driven by regulatory demands for traceability and the rising number of biologics on the market.
Strategic Partnerships and Consolidation
Mergers and acquisitions are reshaping the industry. In January 2025 Cold Chain Technologies acquired Tower Cold Chain, expanding its reusable packaging portfolio. Sonoco’s sale of ThermoSafe and partnerships like Peli BioThermal’s collaboration with Biocair illustrate a trend toward scaling and innovation.
Regional Innovations
Southeast Asia is emerging as a center for cold chain innovation with initiatives like blockchain based tracking, solar powered storage and AI assisted logistics. Portable cryogenic freezers enable ultra cold transport in remote areas.
Summary of Trends and Impact
| Trend | Description | Practical significance |
| Automation & robotics | Automated storage and retrieval systems and robotic handling improve accuracy and reduce labour dependence | Enables 24/7 operations, reduces errors and enhances safety |
| Sustainability | Reusable, recyclable and biodegradable packaging; energy efficient refrigeration | Lowers carbon footprint, meets consumer expectations and may reduce costs |
| AI & predictive analytics | Machine learning models optimize routes, forecast demand and predict equipment failures | Reduces waste and ensures timely deliveries |
| Blockchain & transparency | Immutable records track every step of the supply chain | Enhances trust, deters counterfeiters and simplifies audits |
| Partnerships & consolidation | Mergers and acquisitions expand portfolios and drive innovation | Provides access to new technologies and integrated services |
| Regional innovation | Emerging markets adopt advanced technologies like solar refrigeration and drones | Improves access to medicines in remote areas and fosters global collaboration |
Frequently Asked Questions
Q1: What is a cold chain breach and how should I respond? A cold chain breach occurs when a product’s temperature strays outside its designated range. Causes include power outages, equipment failures or prolonged unloading. Immediately quarantine the product, investigate the cause, document the incident and determine viability based on stability data.
Q2: Which vaccines require ultra cold storage? Some COVID 19 mRNA vaccines (e.g., Pfizer–BioNTech) must be stored between –80 °C and –60 °C; Moderna’s vaccine requires –25 °C to –15 °C but can be refrigerated for 30 days. Gene and cell therapies often need –70 °C or lower.
Q3: What are the key DSCSA deadlines in 2025? Manufacturers and repackagers must comply by May 27 2025; wholesale distributors by August 27 2025; and dispensers with more than 26 employees by November 27 2025. Small dispensers have until November 27 2026.
Q4: How does predictive analytics reduce waste? Predictive analytics uses data from IoT sensors to identify equipment failures and route disruptions before they happen, reducing unplanned downtime by up to 50 % and lowering repair costs by 10–20 %.
Q5: How can I make my cold chain more sustainable? Opt for reusable and recyclable packaging, invest in energy efficient refrigeration, and consider renewable energy sources like solar power. Conduct life cycle assessments and work with partners committed to sustainability.
Q6: Does blockchain really improve cold chain monitoring? Yes. Blockchain provides tamper proof records of shipments and conditions, ensuring that stakeholders can verify temperature, humidity and transit times. When combined with IoT sensors, blockchain offers real time visibility and simplifies audits.
Summary and Recommendations
The pharmaceutical cold chain is evolving rapidly. Standardised temperature ranges, validated equipment, digital monitoring and trained personnel remain the foundation of good cold chain practice. In 2025, global regulations such as the DSCSA, EU GDP and URAC 5.0 raise the bar for traceability and documentation. Technological innovations – IoT sensors, AI analytics, blockchain, drones and sustainable refrigeration – provide unprecedented visibility and efficiency. The market is expanding as biologics and cell therapies gain prominence, making robust cold chain systems indispensable.
To stay ahead:
Assess your current processes: Map every step of your cold chain, identify potential failure points and benchmark against regulatory standards.
Invest in technology: Deploy IoT sensors, AI analytics and blockchain to achieve end to end visibility and predictive capabilities.
Validate and document: Ensure all equipment, packaging and processes are validated to GDP, ISTA and DSCSA standards; maintain accurate records to demonstrate compliance.
Train and educate: Conduct regular training and scenario based drills for staff, covering emergency response and regulatory updates.
Prioritise sustainability: Choose reusable and recyclable packaging, energy efficient refrigeration and renewable energy sources to meet environmental goals.
By adopting these practices and monitoring emerging trends, you can protect patient safety, reduce waste and meet the stringent compliance requirements of 2025 and beyond.
About Tempk
We are Tempk, a specialist in temperature controlled packaging and monitoring solutions. We design and manufacture insulated boxes, reusable pallet shippers and phase change materials that maintain precise temperatures for extended periods. Our products integrate IoT sensors, cloud monitoring and predictive analytics, providing real time visibility and compliance with DSCSA and GDP standards. We commit to sustainable materials and reusable designs to reduce environmental impact while lowering total cost of ownership. Whether you need ultra cold solutions for gene therapies or reliable 2 °C–8 °C shipments, Tempk offers validated options tailored to your needs.
Call to Action: Contact our experts to assess your cold chain requirements and explore tailored monitoring solutions. We offer consultations, product demonstrations and complete packages that align with your regulatory and operational needs.
